Key result
Higher serum albumin-to-creatinine ratio is linked to ~48% fewer 28-day readmissions in elderly HF patients.
Why the study?
The relationship between serum albumin-to-serum creatinine ratio (sACR) and readmission in elderly heart failure patients was not well established.
Does a higher serum albumin-to-creatinine ratio (sACR) reduce readmission in elderly heart failure patients?
Cohort (n=1,725)
Does a higher serum albumin-to-creatinine ratio (sACR) reduce readmission in elderly heart failure patients?
Higher serum albumin-to-creatinine ratio is independently associated with a lower risk of 28-day, 3-month, and 9-month readmission in elderly heart failure patients.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in elderly Chinese HF; leaves open need for prospective validation before clinical use.
INTRODUCTION: This study aimed to investigate the relationship between the serum albumin-to-serum creatinine ratio (sACR) and readmission in elderly heart failure patients. METHODS: We conducted a retrospective cohort study using data from the PhysioNet Restricted Health Data database. The exposure variable was sACR and the outcome variable readmission. Multivariate logistic regression and subgroup analyses were performed to assess the independent association between sACR and readmission. Smooth curve fits were applied to examine the nonlinear relationship. We employed multiple imputation and E-value sensitivity analyses to assess the robustness of our results. RESULTS: Our study included 1,725 participants, of whom 40.6% were male, 59.2% were aged 60-79 years, and 40.8% were aged 80 years and older. After adjusting for potential confounders, we found that for each unit increase in sACR, the 28-day readmission rate decreased by 48% (odds ratio [OR] = 0.52, 95% CI: 0.29-0.95, p = 0.003). The 28-day readmission rate was significantly higher in the low sACR group (sACR <0.32) than in the high sACR group (sACR >0.51) (OR = 0.47, 95% CI: 0.3-0.76, p = 0.002). Similar results were observed for 3-month and 9-month readmission. Subgroup analysis showed no significant interactions. A nonlinear relationship was observed between the sACR and readmission. Sensitivity analyses have confirmed the robustness of our results. CONCLUSION: There is a negative association between sACR and readmission in Chinese heart failure patients. Our study may offer novel insights into the management of heart failure readmissions.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2024) conducted a cohort in Heart failure (n=1,725). Serum albumin-to-creatinine ratio (sACR) vs. Lower sACR was evaluated on 28-day readmission (OR 0.52, 95% CI 0.29-0.95, p=0.003). In elderly heart failure patients, each unit increase in serum albumin-to-creatinine ratio was associated with a 48% reduction in 28-day readmission.
Synapse has enriched 10 related papers. Consider them for comparative context: